One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.

📄 Paper Details

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-m

Yousuf Muhammad; Fathima Saubia; Alsugair Ali Khalid A; Wu Samuel J; Abdelmagid Maymona G; Patel Shraddha P; Faldu Priyansh C; Abdelaziz Rania M; Csizmar Clifford M; Mangaonkar Abhishek A; Zepeda Mend

Blood cancer journal PubMed DOI

Abstract

Blood Cancer Journal - One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models...

One vs. 2 vs. &#x2265;3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol.